Picture of Kiniksa Pharmaceuticals International logo

KNSA — Kiniksa Pharmaceuticals International News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Kiniksa Pharmaceuticals Provides Corporate And Portfolio Update

Kiniksa Pharmaceuticals Ltd  KNSA.O :
    * KINIKSA PHARMACEUTICALS PROVIDES CORPORATE AND PORTFOLIO
UPDATE
    * KINIKSA PHARMACEUTICALS LTD - CASH RESERVES EXPECTED TO
FUND
OPERATIONS INTO AT LEAST 2025
    * KINIKSA PHARMACEUTICALS LTD -  DATA OF KPL-404 PHASE 2
TRIAL IN
RHEUMATOID ARTHRITIS EXPECTED IN 1H 2024

Source text for Eikon:  ID:nGNX5TxFRq 
Further company coverage:  KNSA.O

Recent news on Kiniksa Pharmaceuticals International

See all news